| Elizabeth J Noyes, DO | |
|
1120 Peachtree Industrial Blvd Ste 208, Suwanee, GA 30024-2013 | |
| (678) 312-8400 | |
| (770) 904-2601 |
| Full Name | Elizabeth J Noyes |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 34 Years |
| Location | 1120 Peachtree Industrial Blvd Ste 208, Suwanee, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275649105 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 156314 (Massachusetts) | Secondary |
| 207Q00000X | Family Medicine | 87290 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northside Hospital Gwinnett | Lawrenceville, GA | Hospital |
| Eastside Medical Center | Snellville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gwinnett Physician Group, Llc | 9133211139 | 88 |
News Archive
Oncotarget published "Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells" which reported that to guide studies in cancer patients, relacorilant, an investigational selective GR modulator that antagonizes cortisol activity, was assessed in various tumor types, with multiple cytotoxic combination partners, and in the presence of physiological cortisol concentrations.
Rice University scientists have developed a big data technique that could have a significant impact on health care. The Rice lab of bioengineer Amina Qutub designed an algorithm called "progeny clustering" that is being used in a hospital study to identify which treatments should be given to children with leukemia.
Lerner Medical Devices, Inc. announced today that Levia®, a novel, in-home, ultraviolet B (UVB) phototherapy device, has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA) for treatment of psoriasis and certain other skin conditions such as vitiligo.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the first quarter ended March 31, 2010.
A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among blood relatives.
› Verified 3 days ago
| Entity Name | Gwinnett Physician Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578574661 PECOS PAC ID: 9133211139 Enrollment ID: O20070822001035 |
News Archive
Oncotarget published "Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells" which reported that to guide studies in cancer patients, relacorilant, an investigational selective GR modulator that antagonizes cortisol activity, was assessed in various tumor types, with multiple cytotoxic combination partners, and in the presence of physiological cortisol concentrations.
Rice University scientists have developed a big data technique that could have a significant impact on health care. The Rice lab of bioengineer Amina Qutub designed an algorithm called "progeny clustering" that is being used in a hospital study to identify which treatments should be given to children with leukemia.
Lerner Medical Devices, Inc. announced today that Levia®, a novel, in-home, ultraviolet B (UVB) phototherapy device, has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA) for treatment of psoriasis and certain other skin conditions such as vitiligo.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the first quarter ended March 31, 2010.
A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among blood relatives.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth J Noyes, DO 1120 Peachtree Industrial Blvd Ste 208, Suwanee, GA 30024-2013 Ph: (678) 312-8400 | Elizabeth J Noyes, DO 1120 Peachtree Industrial Blvd Ste 208, Suwanee, GA 30024-2013 Ph: (678) 312-8400 |
News Archive
Oncotarget published "Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells" which reported that to guide studies in cancer patients, relacorilant, an investigational selective GR modulator that antagonizes cortisol activity, was assessed in various tumor types, with multiple cytotoxic combination partners, and in the presence of physiological cortisol concentrations.
Rice University scientists have developed a big data technique that could have a significant impact on health care. The Rice lab of bioengineer Amina Qutub designed an algorithm called "progeny clustering" that is being used in a hospital study to identify which treatments should be given to children with leukemia.
Lerner Medical Devices, Inc. announced today that Levia®, a novel, in-home, ultraviolet B (UVB) phototherapy device, has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA) for treatment of psoriasis and certain other skin conditions such as vitiligo.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the first quarter ended March 31, 2010.
A study by researchers at Mayo Clinic published this week in the Journal of Clinical Oncology suggests that all women with a breast cancer diagnosis under the age of 66 be offered germline genetic testing to determine if they have a gene mutation known to increase the risk of developing other cancers and cancers among blood relatives.
› Verified 3 days ago
Avril Patrice Daisley Shongo, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3312 Heathchase Ln, Address Line 2, Suwanee, GA 30024 Phone: 678-783-4860 | |
Dr. Westly Adrian Bailey, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3890 Johns Creek Pkwy, Ste 230, Suwanee, GA 30024 Phone: 770-623-1331 Fax: 770-623-5674 | |
Usha Musunuru, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4485 Tench Rd, Ste120, Suwanee, GA 30024 Phone: 770-932-7605 Fax: 770-932-7608 | |
Benjamin Morrison, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3925 Johns Creek Ct Ste A, Suwanee, GA 30024 Phone: 770-709-6922 Fax: 770-709-6910 | |
Dr. Scott Dee Griffith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4310 Johns Creek Pkwy, Ste 100, Suwanee, GA 30024 Phone: 678-234-2332 | |
Khushbuben Patel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4235 Johns Creek Pkwy Ste A, Suwanee, GA 30024 Phone: 770-442-1911 | |
Sujatha Lingatlu, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3135 Mathis Airport Pkwy, Ste. 200, Suwanee, GA 30024 Phone: 770-886-7711 Fax: 770-886-7698 |